EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:133008 - Epclusa
| ChEBI ID | CHEBI:133008 |
| ChEBI Name | Epclusa |
| Stars | |
| Definition | A mixture composed of sofosbuvir and velpatasvir (trade name Epclusa) that is used for treatment of patients with chronic hepatitis C of all six major genotypes. |
| Last Modified | 15 August 2016 |
| Submitter | Steve |
| Roles Classification |
|---|
| Biological Roles: | antiviral drug A substance used in the prophylaxis or therapy of virus diseases. hepatitis C protease inhibitor An inhibitor of hepatitis C protease, an enzyme required for production of proteins needed for viral assembly. |
| Application: | antiviral drug A substance used in the prophylaxis or therapy of virus diseases. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Epclusa (CHEBI:133008) has part sofosbuvir (CHEBI:85083) |
| Epclusa (CHEBI:133008) has part velpatasvir (CHEBI:133009) |
| Epclusa (CHEBI:133008) has role antiviral drug (CHEBI:36044) |
| Epclusa (CHEBI:133008) has role hepatitis C protease inhibitor (CHEBI:64924) |
| Epclusa (CHEBI:133008) is a mixture (CHEBI:60004) |
| Synonyms | Source |
|---|---|
| Velpatasvir/Sofosbuvir | ChemIDplus |
| Sofosbuvir mixture with velpatasvir | ChemIDplus |
| Sofosbuvir/velpatasvir | ChemIDplus |
| Sofosbuvir and velpatasvir | ChemIDplus |
| Citations |
|---|